DK3790870T3 - Cyclopentanforbindelser - Google Patents

Cyclopentanforbindelser Download PDF

Info

Publication number
DK3790870T3
DK3790870T3 DK19724152.4T DK19724152T DK3790870T3 DK 3790870 T3 DK3790870 T3 DK 3790870T3 DK 19724152 T DK19724152 T DK 19724152T DK 3790870 T3 DK3790870 T3 DK 3790870T3
Authority
DK
Denmark
Prior art keywords
cyclopentane compounds
cyclopentane
compounds
Prior art date
Application number
DK19724152.4T
Other languages
Danish (da)
English (en)
Inventor
Weitao Pan
Xiaolin Zhang
Grigorios Nikitidis
Jenny Susanna Marika Lindhagen
Original Assignee
Dizal Jiangsu Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dizal Jiangsu Pharmaceutical Co Ltd filed Critical Dizal Jiangsu Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK3790870T3 publication Critical patent/DK3790870T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/08Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK19724152.4T 2018-05-11 2019-05-09 Cyclopentanforbindelser DK3790870T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN2018086503 2018-05-11
PCT/EP2019/061888 WO2019215268A1 (en) 2018-05-11 2019-05-09 Cyclopentane compounds

Publications (1)

Publication Number Publication Date
DK3790870T3 true DK3790870T3 (da) 2023-05-08

Family

ID=66542241

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19724152.4T DK3790870T3 (da) 2018-05-11 2019-05-09 Cyclopentanforbindelser

Country Status (16)

Country Link
US (2) US11274091B2 (https=)
EP (1) EP3790870B1 (https=)
JP (1) JP7418354B2 (https=)
KR (1) KR102806779B1 (https=)
CN (1) CN112424182B (https=)
AR (1) AR115382A1 (https=)
AU (1) AU2019266525B2 (https=)
BR (1) BR112020023065A2 (https=)
CA (1) CA3099507A1 (https=)
DK (1) DK3790870T3 (https=)
ES (1) ES2944735T3 (https=)
MX (1) MX2020012065A (https=)
PT (1) PT3790870T (https=)
TW (1) TWI830733B (https=)
UY (1) UY38229A (https=)
WO (1) WO2019215268A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI830733B (zh) * 2018-05-11 2024-02-01 中國大陸商迪哲(江蘇)醫藥有限公司 環戊烷化合物
JP7594274B2 (ja) 2019-10-24 2024-12-04 国立大学法人大阪大学 難聴の予防および/または治療用医薬組成物
WO2025008249A1 (en) 2023-07-06 2025-01-09 Basf Se Triazole compounds for the control of invertebrate pests

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004017930A1 (de) 2004-04-14 2005-11-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
WO2006001958A2 (en) * 2004-05-21 2006-01-05 Merck & Co., Inc. Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
EP2049500B1 (en) * 2006-07-06 2011-09-07 Array Biopharma, Inc. Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
CN102015708B (zh) * 2008-01-09 2014-03-26 阵列生物制药公司 作为akt蛋白激酶抑制剂的嘧啶基环戊烷
PT2370442E (pt) * 2008-11-26 2013-06-27 Pfizer 3-aminociclopentanocarboxamidas como moduladores de receptor de quimiocina
US7893099B2 (en) * 2009-06-11 2011-02-22 Hoffman-La Roche Inc. Cyclopentane derivatives
EP2368876A1 (en) 2010-03-01 2011-09-28 Sanofi Derivatives of aminoindanes, their preparation and their application in therapeutics
CN105308040B (zh) * 2013-06-21 2019-06-04 默克专利股份公司 1,3-二氨基环戊烷甲酰胺衍生物
SG11201600726QA (en) * 2013-07-29 2016-03-30 Merck Patent Gmbh 1,3-disubstituted cyclopentane derivatives
TWI830733B (zh) * 2018-05-11 2024-02-01 中國大陸商迪哲(江蘇)醫藥有限公司 環戊烷化合物

Also Published As

Publication number Publication date
UY38229A (es) 2019-11-29
AR115382A1 (es) 2021-01-13
JP2021523178A (ja) 2021-09-02
US12378218B2 (en) 2025-08-05
AU2019266525A1 (en) 2020-11-26
KR102806779B1 (ko) 2025-05-12
EP3790870B1 (en) 2023-04-19
EP3790870A1 (en) 2021-03-17
BR112020023065A2 (pt) 2021-02-02
KR20210018287A (ko) 2021-02-17
PT3790870T (pt) 2023-05-05
US20210070733A1 (en) 2021-03-11
CN112424182B (zh) 2023-05-23
AU2019266525B2 (en) 2024-06-13
CA3099507A1 (en) 2019-11-14
US20220194922A1 (en) 2022-06-23
JP7418354B2 (ja) 2024-01-19
MX2020012065A (es) 2021-02-26
TW202016087A (zh) 2020-05-01
US11274091B2 (en) 2022-03-15
ES2944735T3 (es) 2023-06-23
CN112424182A (zh) 2021-02-26
WO2019215268A1 (en) 2019-11-14
TWI830733B (zh) 2024-02-01

Similar Documents

Publication Publication Date Title
FIC20253006I1 (fi) Linvoseltamabi
FIC20260010I1 (fi) imlunestrantti
EP3890716A4 (en) COMBINATION THERAPIES
LT3810602T (lt) Junginiai
EP3846674C0 (en) VAGINAL SPECULUM
EP3849534A4 (en) COMBINATION THERAPIES
EP3555124C0 (en) TCR NYESO
EP3781060A4 (en) CRYOPROBE
EP3784463A4 (en) Fluorosulfones
EP3872558A4 (en) OPTICAL ISOLATOR
EP3810860C0 (en) COUPLER
HUE065134T2 (hu) Vegyületek
EP3792200A4 (en) TANK TANK
EP3745904C0 (de) Stockgriff
LT3867247T (lt) Naujieji junginiai
EP3878374A4 (en) Occlusion device
EP3721129A4 (en) CRYOSPHERE
DK3790870T3 (da) Cyclopentanforbindelser
EP3902806C0 (en) THIENOPYRIDINONE COMPOUNDS
EP3844177A4 (en) COMBINATION THERAPIES
DK3587968T3 (da) Fluidsystem
PL3880011T3 (pl) Sposób
EP3773733A4 (en) METALLO-LIOTHYRONINE
EP3787554A4 (en) STENT TRANSPLANT
DK3752258T3 (da) Trampolin